Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1995-05-17
1998-07-07
Feisee, Lila
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5302873, 5303887, 435 691, 4351723, 4353201, 435326, 435328, 435334, 435343, 536 2353, C07K 1618, C07K 1628, C12P 510, C07H 2104
Patent
active
057770859
ABSTRACT:
Humanized immunoglobulins specifically reactive with GPIIb/IIIa proteins are prepared employing recombinant DNA technology for use in, e.g., treatment of various thrombosis-related disorders.
REFERENCES:
Coller et al., "A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa," J. Clin. Invest. 72:325-338 (1983).
Coller et al., "Abolition of in vitro platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor," Circulation 80(6):1766-1774 (1989).
Coller et al., "Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model," Blood 68(3):783-786 (1986).
Co et al., "Humanized antibodies for antiviral therapy," Proc. Natl. Acad. Sci. USA 88:2869-2873 (1991).
Daugherty et al., "Polymerase chain reaction facilitates the cloning, CDR-grafting, and rapid expression of a murine monoclonal antibody directed against the CD18 component of leukocyte integrins," Nuc. Acids Res. 19:2471-2476 (1991).
Gorman et al., "Reshaping a therapeutic CD4 antibody," Proc. Natl. Acad. Sci. 88:4181-4185 (1991).
Harris et al., "Therapeutic antibodies--the coming of age," Tibtech 11:42-44 (1993).
Heinrich et al., "Monoclonal antibodies against human platelet membrane glycoproteins IIb-IIIa (II. Different Effects on Platelet Function)," Thrombosis Research 38:547-559 (1985).
Jones et al., "Replacing the complementarity-determining regions in a human antibody with those from a mouse," Nature 321:522-525 (1986).
Kettleborough et al., "Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation," Protein Engineering 4:773-783 (1991).
Nugent et al., "A human monoclonal autoantibody recognizes a neoantigen on glycoprotein IIIA expressed on stored and activated platelets," Blood 70(1):16-22 (1987).
Pidard et al., "Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets," J. of Bio. Chemistry, 258(20):12582-12586 (1983).
Queen et al., "A humanized antibody that binds to the interleukin 2 receptor," Proc. Natl. Acad. Sci. USA 86:10029-10033 (1989).
Riechmann et al., "Reshaping human antibodies for therapy," Nature 332:323-327 (1988).
Routledge et al., "A humanized monovalent CD3 antibody which can activate homologous complement," Eur. J. Immunol. 21: 2717-2725 (1991).
Shearman et al., "Construction, expression and characterization of humanized antibodies directed against the human .alpha./.beta. T cell receptor," J. Immunol. 147(12):4366-4373 (1991).
Tempest et al., "Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo," Bio/Technology 9:226-271 (1991).
S. Bhattacharya et al., "Chimeric humanized monoclonal antiplatelet antibody 7E3 produces prolonged dose-dependent inhibition of platelet function," Eur. Heart J., 12(Abstr. Suppl):26 (1991). (Abstracts selected for presentation at the XIIIth Congress of the European Society of Cardiology, Amsterdam, Netherlands, Aug. 18-22, 1991).
T. Kunicki et al., "Nucleotide sequence of the human autoantibody 2E7 specific for the platelet integrin IIb heavy chain," J. Autoimmun., 4(3):433-446 (Jun., 1991).
R. Taub et al., "A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen," J. Biol. Chem., 264(1) :259-265 (Jan. 5, 1989).
64th Scientific sessions of the American Heart Association, Anaheim, California, USA, Nov. 11-14, 1991. Circulation 84 (4 Suppl.), 1991.
Yano et al. Japan J. Thromb Hemostas. 2:403 (1991).
Co et al. J. Immunol. 152: 2968-2976 (1994).
Co Man Sung
Tso J. Yun
Feisee Lila
Gambel Phillip
Protein Design Labs, Inc.
LandOfFree
Humanized antibodies reactive with GPIIB/IIIA does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Humanized antibodies reactive with GPIIB/IIIA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Humanized antibodies reactive with GPIIB/IIIA will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1207248